Loading…

S208: EFFICACY AND SAFETY OF ZANDELISIB ADMINISTERED BY INTERMITTENT DOSING (ID) IN PATIENTS WITH RELAPSED OR REFRACTORY (R/R) FOLLICULAR LYMPHOMA: PRIMARY ANALYSIS OF THE GLOBAL PHASE 2 STUDY TIDAL

Saved in:

Bibliographic Details
Published in:	HemaSphere 2022-06, Vol.6, p.109-110
Main Authors:	Zelenetz, A., Jurczak, W., Ribrag, V., Linton, K., Collins, G., Lopéz-Jiménez, J., Reddy, N., Mengarelli, A., Phillips, T., Musuraca, G., Sheehy, O., Li, J., Xu, W., Azoulay, M., Ghalie, R., Zinzani, P. L.
Format:	Article
Language:	English
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!